Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenia Spectrum Disorders
100%
Hallucinations
40%
Schizophrenia
39%
Antipsychotics
36%
Raloxifene
32%
Estrogen
27%
Psychosis
26%
Postmenopausal Women
25%
Natural Language Processing
21%
Antipsychotic Medication
20%
Healthy Controls
19%
Patients with Schizophrenia
16%
Prolactin
16%
Acoustics
14%
Auditory Hallucinations
13%
First-episode Psychosis
12%
Psychiatry
11%
Loneliness
11%
Adjunctive Therapy
11%
Double-blind Clinical Trial
11%
Sense of Presence
11%
Language Disturbances
10%
Nonclinical
10%
Social Deafferentation
10%
Treatment Monitoring
10%
Acoustic Markers
10%
Semantic Markers
10%
Cross-linguistic
10%
Computational Psycholinguistics
10%
Perceptual Modalities
10%
Voice-hearers
10%
Disease Severity
10%
Disease Cognition
10%
Treatment Response
10%
Genetic Variants
10%
COMT Gene
10%
ESR1 mutation
10%
Developmental Mechanisms
10%
Acoustic-prosodic Features
10%
General Population Sample
10%
Network Analysis
10%
Disturbed Sleep
10%
Other Psychiatric Disorders
10%
Machine Learning Approach
10%
Psycholinguistic Approach
10%
Spontaneous Speech
9%
Female-specific
9%
Symptom Severity
9%
Psychotic Symptoms
8%
Receptor Occupancy
8%
Neuroscience
Schizophrenia Spectrum Disorder
64%
Schizophrenia
54%
Hallucination
40%
Psychosis
30%
Antipsychotic
22%
Raloxifene
21%
Natural Language Processing
20%
Estrogen
20%
Prolactin
14%
Biological Marker
14%
Mental Disorder
11%
Genetics
11%
Linguistics
11%
Receptor Occupancy
10%
Anxiety Disorder
10%
Network Analysis
10%
Psycholinguistics
10%
Negative Syndrome
7%
Social Anxiety Disorder
6%
Placebo
5%
Positive Syndrome
5%
